CAMKK2 and cancer: IP3 receptor ITPR3 phosphorylation at serine 1832 residue, which is a PKA phosphosite47, was enhanced in cancer cells treated with CAF-depleted CM in addition to calmodulin and phosphorylated calcium/calmodulin-dependent protein kinase kinase 2 (CaMKK2).